Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-18
SponsorGlobal Foundation for the Care of Newborn Infants

About this trial

The objective of this study is to examine the long-term impact of having a child with Bronchopulmonary Dysplasia (BPD) on the parents and caregivers from the time of diagnosis through adulthood. The primary focus will be on parents and caregivers of children until the age of 18 (\< 18) years who were diagnosed with BPD as newborns. Data will be collected through an online questionnaire in France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland), and the United States. It will ask about inclusion and exclusion criteria, background information (caregiver, child, and family situation), the child's medical situation, parental health-related quality of life (HRQoL), health literacy, feelings, support structures, and economic burden of the family.

Eligibility criteria

Qualifiers

Being a parent or primary caregiver of a child until the age of 18 years (0 to under 18 years),

who was born preterm (before 37 weeks of gestation),

who has been discharged from their initial hospital stay after birth,

who suffered from BPD in the newborn period and

Disqualifiers

Other family members than parents/primary caregivers

Parents or primary caregivers

of a child older/equal than 18 years of age

of a child with BPD who has not been discharged yet

Trial design

Treatments tested in this trial

  • N/A, no intervention, participation in survey

Treatment groups

480 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Global Foundation for the Care of Newborn Infants

Lead sponsor

European Society for Paediatric Research (ESPR)

Collaborator

Union of European Neonatal and Perinatal Societies (UENPS)

Collaborator

European Respiratory Society (ERS)

Collaborator